Literature DB >> 8702556

Identification and cDNA cloning of 35-kDa phosphatidic acid phosphatase (type 2) bound to plasma membranes. Polymerase chain reaction amplification of mouse H2O2-inducible hic53 clone yielded the cDNA encoding phosphatidic acid phosphatase.

M Kai1, I Wada, S Imai, F Sakane, H Kanoh.   

Abstract

We previously described the purification of an 83-kDa phosphatidic acid phosphatase (PAP) from the porcine thymus membranes (Kanoh, H., Imai, S.-i., Yamada, K. and Sakane, F.(1992) J. Biol. Chem. 267, 25309-25314). However, we found that a minor 35-kDa protein could account for the PAP activity when the purified enzyme preparation was further analyzed. We thus determined the N-terminal sequence of the 35-kDa candidate protein and prepared antipeptide antibody against the determined sequence, MFDKTRLPYVALDVL. The antibody almost completely precipitated the purified enzyme activity. Furthermore, the antibody precipitated from the radioiodinated enzyme preparation a single 35-kDa protein, which was converted to a 29-kDa form when treated with N-glycanase. We also found that the immunoprecipitable PAP activity was exclusively associated with the plasma membranes of porcine thymocytes. These results indicated that the 35-kDa glycosylated protein represents the plasma membrane-bound (type 2) PAP. We surprisingly noted that the N-terminal sequence of the porcine PAP was almost completely conserved in the internal sequence encoded by a mouse partial cDNA clone, hic53, reported as a H2O2-inducible gene (Egawa, K., Yoshiwara, M., Shibanuma, M., and Nose, K.(1995) FEBS Lett. 372, 74-77). We thus amplified from the mouse kidney RNA the hic53 clone by polymerase chain reaction, and obtained a cDNA encoding a novel protein of 283 amino acid residues with a calculated Mr of 31,894. Methionine reported as an internal residue was found to serve as an initiator, and the C-terminal 64 residues were lacking in hic53. The protein contains several putative membrane-spanning domains and two N-glycosylation sites. When transfected into 293 cells, the cDNA gave more than 10-fold increase of the membrane-bound PAP activity, which could be precipitated by the antipeptide antibody. In [35S]methionine-labeled cells, the translational product was confirmed to be a 35-kDa protein, which became 30 kDa in cells treated with tunicamycin, an inhibitor of N-glycosylation. We thus succeeded first in identifying the porcine type 2 PAP and subsequently in determining the primary structure of a mouse homolog of the PAP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702556     DOI: 10.1074/jbc.271.31.18931

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools.

Authors:  Jaclyn Long; Peter Darroch; Kah Fei Wan; Kok Choi Kong; Nicholas Ktistakis; Nigel J Pyne; Susan Pyne
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

2.  An unexpected structural relationship between integral membrane phosphatases and soluble haloperoxidases.

Authors:  A F Neuwald
Journal:  Protein Sci       Date:  1997-08       Impact factor: 6.725

Review 3.  Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.

Authors:  Xiaoyun Tang; Matthew G K Benesch; David N Brindley
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

4.  Crystal structures and biochemical studies of human lysophosphatidic acid phosphatase type 6.

Authors:  Jun Li; Yu Dong; Xingru Lü; Lu Wang; Wei Peng; Xuejun C Zhang; Zihe Rao
Journal:  Protein Cell       Date:  2013-06-26       Impact factor: 14.870

5.  Identification of structurally important domains of lipid phosphate phosphatase-1: implications for its sites of action.

Authors:  Q X Zhang; C S Pilquil; J Dewald; L G Berthiaume; D N Brindley
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

6.  Cloning and characterization of a novel human phosphatidic acid phosphatase type 2, PAP2d, with two different transcripts PAP2d_v1 and PAP2d_v2.

Authors:  Liyun Sun; Shaohua Gu; Yaqiong Sun; Dan Zheng; Qihan Wu; Xin Li; Jianfeng Dai; Jianliang Dai; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

7.  Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.

Authors:  Zahia Touat-Hamici; Henri Weidmann; Yuna Blum; Carole Proust; Hervé Durand; Francesca Iannacci; Veronica Codoni; Pauline Gaignard; Patrice Thérond; Mete Civelek; Sonia A Karabina; Aldons J Lusis; François Cambien; Ewa Ninio
Journal:  Cardiovasc Res       Date:  2016-09-30       Impact factor: 10.787

8.  Purification and characterization of a lysophosphatidic acid-specific phosphatase.

Authors:  M Hiroyama; T Takenawa
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

9.  Fly and mammalian lipid phosphate phosphatase isoforms differ in activity both in vitro and in vivo.

Authors:  Camilla Burnett; Ken Howard
Journal:  EMBO Rep       Date:  2003-07-11       Impact factor: 8.807

10.  Plasticity-related gene 5 (PRG5) induces filopodia and neurite growth and impedes lysophosphatidic acid- and nogo-A-mediated axonal retraction.

Authors:  Thomas Broggini; Robert Nitsch; Nic E Savaskan
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.